1. He Z#, Ren L#, Yang J#, Guo L#, Feng L#, Ma C, Wang X, Leng Z, Tong X, Zhou W, Wang G, Zhang T, Guo Y, Wu C, Wang Q, Liu M, Wang C, Jia M, Hu X, Wang Y, Zhang X, Hu R, Zhong J, Yang J, Dai J, Chen L, Zhou X, Wang J*, Yang W*, Wang C*.Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.Lancet.2021.397(10279).1075-1084.SCI |
2. Chen S, Yang J, Yang W,Wang C*, Bärnighausen T.COVID-19 control in China during mass population movements at New Year.Lancet.2020.395(10226).764-766.SCI |
3. Wang Y#, Zhang D#, Du G#, Du R#, Zhao J#, Jin Y#, Fu S#, Gao L#, Cheng Z#, Lu Q#, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S,...... Horby PW, Cao B, Wang C*.Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet.2020.395(10236).1569-1578.SCI |
4. Wang C*, Horby PW, Hayden FG, Gao GF.A novel coronavirus outbreak of global health concern.Lancet.2020.395(10223).470-473.SCI |
5. Xiao D, Chen, ZM, Wu SN, Huang KW, Xu JY, Yang L, Xu YJ, Zhang XY, Bai CX, Kang J, Ran PX, Shen HH, Wen, FQ, Yao WZ, Sun TY, Shan GL, Yang T, Lin YX, Zhu JG, Wang RY, Shi ZH, Zhao JP, Ye XW, Song YL, Wang QY, Hou G, Zhou YM, Li W, Ding LR, ......Wang C*; China Pulmonary Health (CPH) Study Group.Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study.Lancet Respir Med.2020.8(11).1081-1093.SCI |
6. Chen S#, Zhang Z#, Yang J, Wang J, Zhai X, Bärnighausen T*, Wang C*.Fangcang shelter hospitals: a novel concept for responding to public health emergencies.Lancet.2020.395(10232).1305-1314.SCI |
7. Wang C, Zhai XM, Zhang XQ, Li LM, Wang JW*, Liu DP, on behalf of Chinese Academy of Medical Sciences.Gene-edited babies: Chinese Academy of Medical Sciences’ response and action.Lancet.2019.393(10166).25-26.SCI |
8. Huang K#, Yang T#, Xu J#, Yang L#, Zhao J#, Zhang X#, Bai C#, Kang J#, Ran P#, Shen H#, Wen F#, Chen Y#, Sun T#, Shan G#, Lin Y#, Xu G#, Wu S#, ......Wang C*; China Pulmonary Health (CPH) Study Group.Prevalence, risk factors, and management of asthma in China: a national cross-sectional study.Lancet.2019.349(10196).407-418.SCI |
9. Zhang Z, Lei JP, Shao X, Dong F, Wang J, Wang DY, Wu SN, Xie WM, Wan J, Chen H, Ji YQ, Yi Q, Xu XM, Yang YH, Zhai ZG, Wang C, on behalf of The China Venous Thromboembolism Study Group.Trends in Hospitalization and In-Hospital Mortality from Venous Thromboembolism, 2007 to 2016, in China.Chest.2019.155(2).342-353.SCI |
10. Zhai ZG, Kan QC, Li WM, Qin XY, Qu JM, Shi YK, Xu RH, Xu YM, Zhang Z, Wang C*, on behalf of the DissolVE-2 investigators. VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism (DissolVE-2)—A Cross-sectional Study.Chest.2019.155(1).114-122.SCI |
11. Wang C*, Chen S, Zhu J, Li W.China's new 4 + 4 medical education programme.Lancet.2019.395(10223).470-473.SCI |
12. Wang C#*, Xu J#, Yang L#, Xu Y#, Zhang X#, Bai C#, Kang J#, Ran P#, Shen H#, Wen F#, Huang K#, Yao W#, Sun T#, Shan G#, Yang T#, Lin Y#, Wu S#, Zhu J#, …… He J*; China Pulmonary Health Study Group.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.Lancet.2018.391(10131).1706-1717.SCI |
13. Shuai Zhang#, Zhenguo Zhai#, Yuanhua Yang#, Jianguo Zhu, Tuguang Kuang, Wanmu Xie, Suqiao Yang, Fangfang Liu, Juanni Gong, Ying H. Shen, Chen Wang*.Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study .International Journal of Cardiology.2016.202.275-281.SCI |
14. Xiao D#, Shi YK, Wang C*.Tobacco in China.Lancet.2014.383(9934).2045-2046.SCI |
15. Zhang YH#, Yang YH, Chen WH, Guo LJ, Liang LR, Zhai ZG, Wang C.China Venous Thromboembolis VTES: Prevalence and Associations of VTE in Patients With Newly Diagnosed Lung Cancer.Chest.2014.146(3).650-658.SCI |
16. Cao B#, Huang GH, Pu ZH, Qu JX, Yu XM, Zhu Z, Dong JP, Gao Y, Zhang YX, Li XH, Liu JH, Wang H, Xu Q, Li H, Xu WB, Wang C*.Emergence of Community-Acquired Adenovirus Type 55 as a Cause of Community-Onset Pneumonia.Chest.2014.145(1).79-86.SCI |
17. Xiao D, Chen Z, Wang C.Effects of a short-term mass-media campaign against smoking.Lancet .2013.S0140-6736(13).61839-5.SCI |
18. Ye H, Zhan QY, Ren YH, Liu XY, Yang C, Wang C*.Cyclic deformation-induced injury and differentiation of rat alveolar epithelial type II cells.Resp Physiol Neurobi.2012.180.237-246.SCI |
19. Xie WM, Zhai ZG, Yang YH, Kuang TG, Wang C*.Free fatty acids inhibit TM-EPCR expression through JNK pathway: an implication for the development of the prothrombotic state in metabolic syndrome.J Thromb Thrombolys.2012.34.468-474.SCI |
20. Wang, C*; Cao, B; Liu, QQ; Zou, ZQ; Liang, ZA; Gu, L; Dong, JP; Liang, LR; Li, XW; Hu, K; He, XS; Sun, YH; An, Y; Yang, T; Cao, ZX; Guo, YM; Wen, XM; Wang, YG; Liu, YL; Jiang, LD..Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan-Yinqiaosan in the Treatment of H1N1 Influenza.ANNALS OF INTERNAL MEDICINE.2011.155(4).217-U53.SCI |
21. Cao, B; Zhao, CJ; Yin, YD; Zhao, F; Song, SF; Bai, L; Zhang, JZ; Liu, YM; Zhang, YY; Wang, H; Wang C*.High Prevalence of Macrolide Resistance in Mycoplasma pneumoniae Isolates from Adult and Adolescent Patients with Respiratory Tract Infection in China.CLINICAL INFECTIOUS DISEASES.2010.51 (2).189-194.SCI |
22. Xu, W; Collet, JP; Shapiro, S; Lin, Y; Yang, T; Wang C*; Bourbeau, J. .Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year.EUROPEAN RESPIRATORY JOURNAL .2010.35 (5).1022-1030.SCI |
23. Chen Wang*, Zhenguo Zhai, Yuanhua Yang, Qi Wu, Zhaozhong Cheng,Lirong Liang.Efficacy and safety of low dose rt-PA for the treatment of acute pulmonary thromboembolism: a randomized multi-center controlled trial.Chest.2010.137(2).254-262.SCI |
24. Zhai, ZG; Wang, J; Zhao, L; Yuan, JXJ; Wang C*..Pulmonary Hypertension in China Pulmonary Vascular Disease: The Global Perspective.CHEST .2010.137 (6).69S-77S, Suppl. S.SCI |
25. Cao, B; Li, XW; Shu, YL; Jiang, N; Chen, SJ; Xu, XY; Wang C*. Natl Influenza Pandemic (H1N1) 20. 2009. .Clinical and Epidemiologic Characteristics of 3 Early Cases of Influenza A Pandemic (H1N1) 2009 Virus Infection, People's Republic of China.EMERGING INFECTIOUS DISEASES .2009.15 (9).1418-1422.SCI |
26. Cao, B; Li, XW; Mao, Y; Wang, J; Lu, HZ; Chen, YS; Liang, ZA; Liang, LR; Zhang, SJ; Zhang, B; Gu, L; Lu, LH; Wang, DY; Wang, C. Natl Influenza Pandemic H1N1 2009. 2009..Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China.NEW ENGLAND JOURNAL OF MEDICINE .2009.361 (26).2507-2517.SCI |
27. Yin YD, Wang C*, Zhai ZG, Pang BS, Yang YH, Huang XX..Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism.J Thromb Thrombolys.2009.27(3).274-279.SCI |
28. Wang C*, Xiao D, Chan KP, Pothirat C, Garza D, Davies S. .Varenicline for smoking cessation: A placebo-controlled, randomized study.Respirology. .2009.14(3). 384-392.SCI |
29. Xu, W; Collet, JP; Shapiro, S; Lin, Y; Yang, T; Wang, C*; Bourbeau, J..Validation and clinical interpretation of the St George's Respiratory Questionnaire among COPD patients, China.Int J Tuberc Lung D.2009.13 (2).181-189.SCI |
30. Wang C*; Zhai, ZG; Yang, YH; Yuan, YD; Cheng, ZZ; Liang, LR; Dai, HP; Huang, KW; Lu, WX; Zhang, ZH; Cheng, XS; Shen, YH. CVTESG. .Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial.RESPIRATORY RESEARCH.2009.10.art. no.-128.SCI |
31. Wang, YX; Wang, J; Wang, C; Liu, J; Shi, LP; Xu, M; Wang, C*.Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells.J Membrane Biol,.2008. 223 (3).151-159 .SCI |
32. Xu, WN; Collet, JP; Shapiro, S; Lin, YX; Yang, T; Platt, RW; Wang, C*; Bourbeau, J..Independent Effect of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Exacerbations and Hospitalizations.Am J Resp Crit Care.2008.178 (9).913-920 .SCI |
33. Wang, C; Wang, J; Zhao, L; Wang, YX; Liu, J; Shi, LP;Xu, M; Wang,C*.Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca2+ entry.J Pharmacol SCI.2008.108 (1).71-78.SCI |
34. Zhu, L; Wang, C*; Yang, YH; Wu, YF; Zhai, ZH; Dai, HP;Pang, BS; Tong, ZH..echocardiography in therapy regimens evaluation in pulmonary embolism.J Thromb Thrombolys.2008.26 (3).251-256.SCI |